Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Accumulated Depreciation

Accumulated Depreciation at other companies

TFX
TeleflexTFX
$1.38B-18.0%
IAR
Integra LifeSciencesIART
$883.31M+15.8%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$382.67M+5.9%
PDE
Pro-Dex, Inc.PDEX
$216K-47.8%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
——
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——

Segments

By geography

See full
US And Canada$19.4M+2.5%
IE$4.05M+18.8%
England And Australia$1.89M+19.0%

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's accumulated depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's accumulated depreciation?
Utah Medical Products (UTMD) reported accumulated depreciation of $54.93M in Q1 2026.
How has Utah Medical Products's accumulated depreciation changed year-over-year?
Utah Medical Products's accumulated depreciation increased by 5.1% year-over-year, from $52.25M to $54.93M.
What is the long-term trend for Utah Medical Products's accumulated depreciation?
Over 5 years (2020 to 2025), Utah Medical Products's accumulated depreciation has grown at a 2.3% compound annual growth rate (CAGR), from $22.58M to $25.34M.
What does accumulated depreciation mean?
Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.